American Healthcare REIT, Inc. 8-K/A

What Happened
American Healthcare REIT, Inc. (AHR) filed an 8-K (Item 5.02) disclosing an employment letter dated March 23, 2026 (effective retroactively as of February 4, 2026) with Jeffrey T. Hanson appointing him as Interim Chief Executive Officer and President. Mr. Hanson will continue to serve as Chairman of the Board while acting as Interim CEO and will serve in the role until removed by the Board.

Key Details

• Base salary: $70,666.67 per month (approximately $848,000 annualized), less applicable withholding.
• 2026 cash bonus: target opportunity of 120% of annualized base salary, pro-rated for the period he serves as Interim CEO.
• Equity awards: two restricted stock unit (RSU) grants, each with a grant-date value of $2,027,075 (total at least $4,054,150). One grant vests on the earlier of March 15, 2027 or within 30 days after the Employment Letter term ends; the other is performance-based with the same grant-date value and prorated if his Interim CEO service ends before Dec 31, 2026.
• Compensation under the Employment Letter replaces any additional compensation for his Board service. The Employment Letter is attached as an exhibit to the filing.

Why It Matters
This filing confirms leadership continuity by formalizing Mr. Hanson’s role as Interim CEO and discloses material compensation that will affect the company’s executive costs and equity structure. The cash and equity awards are substantial (notably the combined RSU grant-date value of about $4.05 million and a high bonus opportunity), which investors should note for potential impacts on reported compensation expense and share dilution. The performance-based RSU and pro-ration terms indicate some alignment with corporate goals and tenure as Interim CEO.